Ying Guo

机构：Tianjin Medical University General Hospital · ORCID：0000-0002-0606-9039

发表论文 67 篇 · 总被引 1308 次 · h-index 20

代表论文

• A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis (2021 · Nature Communications · 被引 140)
• Liquiritigenin Confers Liver Protection by Enhancing NRF2 Signaling through Both Canonical and Non-canonical Signaling Pathways (2023 · Journal of Medicinal Chemistry · 被引 34)
• A Glucose Metabolic Intervention Nanoplatform for Enhanced Chemodynamic Therapy and Sensitized Photothermal Therapy of Hepatocellular Carcinoma (2023 · ACS Applied Materials & Interfaces · 被引 32)
• Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury (2020 · Cell & Bioscience · 被引 31)
• Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2‐SLC7A11 Signaling Pathway (2025 · Advanced Science · 被引 30)
• miR ‐3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10 (2022 · Phytotherapy Research · 被引 27)